SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination

被引:151
作者
Li, Pengfei [1 ]
Wang, Yining [1 ]
Lavrijsen, Marla [1 ]
Lamers, Mart M. [2 ]
de Vries, Annemarie C. [1 ]
Rottier, Robbert J. [3 ,4 ]
Bruno, Marco J. [1 ]
Peppelenbosch, Maikel P. [1 ]
Haagmans, Bart L. [2 ]
Pan, Qiuwei [1 ]
机构
[1] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Med Ctr, Erasmus MC, Virosci Dept, Rotterdam, Netherlands
[3] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands
[4] Univ Med Ctr, Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands
关键词
D O I
10.1038/s41422-022-00618-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:322 / 324
页数:3
相关论文
共 13 条
  • [1] HEAVILY MUTATED OMICRON VARIANT PUTS SCIENTISTS ON ALERT
    Callaway, Ewen
    [J]. NATURE, 2021, 600 (7887) : 21 - 21
  • [2] Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
    Dejnirattisai, Wanwisa
    Shaw, Robert H.
    Supasa, Piyada
    Liu, Chang
    Stuart, Arabella S. V.
    Pollard, Andrew J.
    Liu, Xinxue
    Lambe, Teresa
    Crook, Derrick
    Stuart, Dave I.
    Mongkolsapaya, Juthathip
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    Screaton, Gavin R.
    [J]. LANCET, 2022, 399 (10321) : 234 - 236
  • [3] Jayk Bernal, NEW ENGL J MED, DOI [10.1056/NEJMoa2116044(2021, DOI 10.1056/NEJMOA2116044(2021]
  • [4] Kozlov Max, 2021, Nature, DOI 10.1038/d41586-021-03829-0
  • [5] An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells
    Lamers, Mart M.
    van der Vaart, Jelte
    Knoops, Kevin
    Riesebosch, Samra
    Breugem, Tim, I
    Mykytyn, Anna Z.
    Beumer, Joep
    Schipper, Debby
    Bezstarosti, Karel
    Koopman, Charlotte D.
    Groen, Nathalie
    Ravelli, Raimond B. G.
    Duimel, Hans Q.
    Demmers, Jeroen A. A.
    Verjans, Georges M. G. M.
    Koopmans, Marion P. G.
    Muraro, Mauro J.
    Peters, Peter J.
    Clevers, Hans
    Haagmans, Bart L.
    [J]. EMBO JOURNAL, 2021, 40 (05)
  • [6] Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n2713
  • [7] An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
    Owen, Dafydd R.
    Allerton, Charlotte M. N.
    Anderson, Annaliesa S.
    Aschenbrenner, Lisa
    Avery, Melissa
    Berritt, Simon
    Boras, Britton
    Cardin, Rhonda D.
    Carlo, Anthony
    Coffman, Karen J.
    Dantonio, Alyssa
    Di, Li
    Eng, Heather
    Ferre, RoseAnn
    Gajiwala, Ketan S.
    Gibson, Scott A.
    Greasley, Samantha E.
    Hurst, Brett L.
    Kadar, Eugene P.
    Kalgutkar, Amit S.
    Lee, Jack C.
    Lee, Jisun
    Liu, Wei
    Mason, Stephen W.
    Noell, Stephen
    Novak, Jonathan J.
    Obach, R. Scott
    Ogilvie, Kevin
    Patel, Nandini C.
    Pettersson, Martin
    Rai, Devendra K.
    Reese, Matthew R.
    Sammons, Matthew F.
    Sathish, Jean G.
    Singh, Ravi Shankar P.
    Steppan, Claire M.
    Stewart, Al E.
    Tuttle, Jamison B.
    Updyke, Lawrence
    Verhoest, Patrick R.
    Wei, Liuqing
    Yang, Qingyi
    Zhu, Yuao
    [J]. SCIENCE, 2021, 374 (6575) : 1586 - +
  • [8] An update on direct antiviral agents for the treatment of hepatitis C
    Stanciu, Carol
    Muzica, Cristina Maria
    Girleanu, Irina
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana-Maria
    Huiban, Laura
    Chiriac, Stefan
    Cuciureanu, Tudor
    Trifan, Anca
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (13) : 1729 - 1741
  • [9] Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
    Toots, Mart
    Yoon, Jeong-Joong
    Cox, Robert M.
    Hart, Michael
    Sticher, Zachary M.
    Makhsous, Negar
    Plesker, Roland
    Barrena, Alec H.
    Reddy, Prabhakar G.
    Mitchell, Deborah G.
    Shean, Ryan C.
    Bluemling, Gregory R.
    Kolykhalov, Alexander A.
    Greninger, Alexander L.
    Natchus, Michael G.
    Painter, George R.
    Plemper, Richard K.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (515)
  • [10] SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
    Wahl, Angela
    Gralinski, Lisa E.
    Johnson, Claire E.
    Yao, Wenbo
    Kovarova, Martina
    Dinnon, Kenneth H., III
    Liu, Hongwei
    Madden, Victoria J.
    Krzystek, Halina M.
    De, Chandrav
    White, Kristen K.
    Gully, Kendra
    Schafer, Alexandra
    Zaman, Tanzila
    Leist, Sarah R.
    Grant, Paul O.
    Bluemling, Gregory R.
    Kolykhalov, Alexander A.
    Natchus, Michael G.
    Askin, Frederic B.
    Painter, George
    Browne, Edward P.
    Jones, Corbin D.
    Pickles, Raymond J.
    Baric, Ralph S.
    Garcia, J. Victor
    [J]. NATURE, 2021, 591 (7850) : 451 - +